glp-1 research Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Science Behind GLP 1 GIP

People with type 2 diabetes who need help with blood sugar control or who also have risk factors for cardiovascular disease are candidates for these medications, according to Diala Alatassi, MD , a double board-certified internal and obesity medicine physician at Endeavor Health in Elmhurst, IL

For all patients diagnosed with diabetes, changes to their diet will be recommended

Proven Results Our patients have successfully achieved their weight loss and bodybuilding goals with the help of GLP-1 receptor agonists

December 2, 2025: Australian Government Issues Warning About Ozempic and Reports of Suicidality, Self-Harm The Therapeutic Goods Administration in Australia (a government agency similar to the FDA in the U.S.) warns that a concerning number of patients who take Ozempic and other GLP-1s reported suicidal ideation and self-harm

GLP-1RA secondary to direct and mechanistic indirect effects on physiological systems have raised a need to further understand their potential in clinical practice